期刊文献+

乙肝基因疫苗系列质粒的构建及其在真核细胞中的表达 被引量:5

Construction of Recombinant Plasmids Containing Genes of HBsAg and Their Expression in the Eukaryotic Cells
下载PDF
导出
摘要 目的 构建一系列乙肝病毒表面抗原大、中、小蛋白的真核细胞表达质粒 ,并研究其在真核细胞中的表达情况。方法 采用常规 PCR法扩增 S、前 S2 - S、前 S1 -前 S2 - S片断 ,利用重叠 PCR法扩增出前 S1 - S片断后 ,分别插入 Rc/ CMV及 p SG5 U TPL/ Flag载体质粒中 ,并在其 ATG起始密码前加入 KOZAK序列后转染 SP2 / 0细胞 ,Western- Blot杂交检测所表达蛋白 ,并用核酸自动分析仪分析所插入片断的核酸序列。结果 插入片断的核苷酸序列与相应的大、中、小蛋白和前 S1 - S蛋白的编码基因一致 ,Western- Blot杂交检测出了相应的目的蛋白。结论 获得了 8个能高效表达乙肝病毒表面抗原大、中、小蛋白和前 S1 - S蛋白的真核细胞表达质粒。 Objective To construct recombinant plasmids expressing L,M,S and pre S 1 S protein of HBsAg. Methods Amplifying segments of S, pre S 2 S, pre S 1 pre S 2 S genes of HBV by PCR and amplifying segment of pre S 1 S by overlap extension PCR; inserting the segments into Rc/CMV and pSG5UTPL/Flag plasmids respectively and exploring their expressions by Western Blot hybridization,identifying the inserting segments by sequencing.Results The sequences of the inserted segments were the same as the genes of S, pre S 2 S, pre S 1 pre S 2 S and pre S 1 S and the results of Western Blot hybridization were positive for the aimed proteins. Conclusion We have gained 8 recombinant plasmids expressing S, M, L and pre S 1 S proteins with high efficacy.
出处 《华西医科大学学报》 CAS CSCD 北大核心 2001年第2期172-174,共3页 Journal of West China University of Medical Sciences
基金 国家自然科学基金!(批准号 3 9670 670 ) 四川省科委"九五"攻关重大项目 四川省计委科研基金资助
关键词 乙肝病毒表面抗原 真核细胞表达质粒 SP2/0细胞 核酸疫苗 HBsAg Plasmid Eukaryotic cell Gene vaccine
  • 相关文献

参考文献4

二级参考文献10

共引文献11

同被引文献17

  • 1Wen-JunGao,Xiao-MouPeng,Dong-YingXie,Qi-FengXie,Zhi-LiangGao,Ji-LuYao,Wen-JunGao.Construction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene[J].World Journal of Gastroenterology,2004,10(20):2979-2983. 被引量:2
  • 2J.萨姆布鲁克 E.F.弗里奇 T.曼尼阿蒂斯.分子克隆实验指南.第2版[M].北京:科学出版社,1999.35—66.
  • 3Guidotti LG. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection [ J ]. Vaccine, 21XI2, Suppl 4: A80 - 82.
  • 4Sing GK, Ladhams A,Amold S, et al. A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients [J]. J Viral Hepat, 2001, 8 (1): 19-29.
  • 5Chisari FV, Ferrai C. Cytotoxic T cells and viral hepatitis [ J ]. J Clin Invest, 1997, 99 (7) : 1472 - 1477.
  • 6Yah J,Liu X,Wang Y, et al. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV - specific antigens and the N - terminal fragment of gp96[ J]. J Gene Med, 2007, 9 (2): 107-121.
  • 7Iuxembourg A, Hannaman D, EUefsen B, et al. Enhancement of immune responses to an HBV DNA vaccine by electroporation [ J ]. Vaccine, 2006, 24 (21): 4490-4493.
  • 8Huang Y, Chen Z,Jia H, et al. Induction of Tcl response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovims expressing HBsAg [J]. Clin Immunol, 2006, 119 (3): 280-290.
  • 9Fissolo N, Riedl P, Reimann J, et al. DNA vaccines prime CD8 + T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence [J]. Eur J Immunol, 2005, 35 (1): 117-127.
  • 10Encke J,zu Putlitz J,Wands JR. DNA Vaccine [J]. Intervirology, 1999, 42: 117 - 124.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部